A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dapagliflozin Impurity 91 - Request Quote

Picture of Dapagliflozin Impurity 91

Dapagliflozin Impurity 91

SZ CAT No:SZ-D015128
CAS No
NA
Mol.F.
C19H21ClO5
Mol.Wt.
364.8
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dapagliflozin Impurity 91 is chemically (2R,3R,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydrofuran-2,3,4-triol. Dapagliflozin Impurity 91 is supplied with detailed characterization data compliant with regulatory guideline. Dapagliflozin Impurity 91 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapagliflozin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Dapagliflozin Impurity 91

Purchase Dapagliflozin Impurity 91

Dapagliflozin Impurity 91 suppliers

Dapagliflozin Impurity 91 manufacturers

Dapagliflozin Impurity 91 price

Order Dapagliflozin Impurity 91

Enquire Dapagliflozin Impurity 91

Dapagliflozin Impurity 91 cost

Dapagliflozin Impurity 91 Supplier

Dapagliflozin Impurity 91 Distributor

Dapagliflozin Impurity 91 for Method Validation

Dapagliflozin Reference Standard

Dapagliflozin Impurity 91 for ANDA Filing

Dapagliflozin Impurity 91 for Forced Degradation Studies

Dapagliflozin Impurity 91 Identification Standards

Dapagliflozin Impurity 91 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,